Triamcinolone Injection Franchise in Ahmedabad

Corticosteroid Injection Supplier in Mumbai

Anti-Inflammatory Injection Distributor in Delhi

Hospital PCD Pharma Franchise in Bangalore

Triamcinolone Injection Stockist in Hyderabad
Corticosteroid Injection Manufacturer & Exporter in Chandigarh

Home/Products /triamcinolone-acetonide-20mg-injection

Triamark 20 Injection

Composition : Triamcinolone Acetonide (20mg) Injection

Dosage Form : Injection

Packaging Type : Vial

Packaging : 20mg

Price : ₹1/-

Triamark 20 Injection contains Triamcinolone Acetonide 20mg, a powerful corticosteroid used for treating severe inflammatory disorders, allergic reactions, and autoimmune conditions. It provides effective reduction in swelling, redness, and pain.

Triamcinolone works by suppressing the immune system and inhibiting inflammatory mediators, delivering rapid relief from acute and chronic inflammatory symptoms. Its high-potency formulation makes it suitable for hospital and critical care settings.

This injection is commonly prescribed for rheumatoid arthritis, severe dermatitis, asthma exacerbations, allergic reactions, and other immune-mediated disorders. The parenteral form ensures quick onset and high bioavailability for effective patient management.

For PCD pharma franchise partners, Triamark 20 Injection is a high-demand corticosteroid product, available at the best price for PCD pharma franchise. Its clinical reliability, strong hospital usage, and prescriber trust make it a valuable addition to any anti-inflammatory or injectable medicine portfolio.

Read More

About the Product

Triamark 20 Injection contains Triamcinolone Acetonide 20mg, a powerful corticosteroid used for treating severe inflammatory disorders, allergic reactions, and autoimmune conditions. It provides effective reduction in swelling, redness, and pain.

Triamcinolone works by suppressing the immune system and inhibiting inflammatory mediators, delivering rapid relief from acute and chronic inflammatory symptoms. Its high-potency formulation makes it suitable for hospital and critical care settings.

This injection is commonly prescribed for rheumatoid arthritis, severe dermatitis, asthma exacerbations, allergic reactions, and other immune-mediated disorders. The parenteral form ensures quick onset and high bioavailability for effective patient management.

For PCD pharma franchise partners, Triamark 20 Injection is a high-demand corticosteroid product, available at the best price for PCD pharma franchise. Its clinical reliability, strong hospital usage, and prescriber trust make it a valuable addition to any anti-inflammatory or injectable medicine portfolio.

Common side effects may include mild pain or irritation at the injection site, fluid retention, increased appetite, or mood changes. Rare but serious effects include adrenal suppression, high blood pressure, increased risk of infections, and severe allergic reactions. Immediate medical attention is recommended if serious symptoms occur.

Triamark 20 Injection is indicated for the treatment of severe allergic reactions, asthma exacerbations, rheumatoid arthritis, dermatologic disorders, autoimmune conditions, and other inflammatory or immune-mediated diseases, as prescribed by a healthcare professional.

Triamark 20 Injection should only be administered by a healthcare professional. Dosage and frequency must be strictly followed. Prolonged use requires monitoring for systemic effects, including blood sugar fluctuations, bone density loss, and immune suppression. Do not abruptly discontinue without medical guidance.

Store Triamark 20 Injection in a cool, dry place, away from direct sunlight and freezing conditions. Keep the vial tightly closed and out of reach of children. Do not use if the solution is discolored or contains particles.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation